new
pathogen
concern
bioterror
brought
ad
urgenc
develop
effici
rapid
method
detect
pathogen
predict
potenti
virul
mani
tradit
diagnost
test
complement
replac
genotyp
analysi
ie
detect
dna
rna
fragment
size
specif
sequenc
nucleic
acid
hybridis
techniqu
increasingli
today
dna
amplif
polymeras
chain
reaction
pcr
express
frequent
found
microbiolog
dna
test
nat
nucleic
acid
amplif
techniqu
nat
refer
number
techniqu
apart
pcr
use
amplifi
dna
eg
ligas
chain
reaction
conveni
descript
pcr
use
interchang
nat
indic
broadli
base
amplif
dna
synthesis
design
dna
probe
primer
necessari
sequenc
organ
dna
identifi
speciesspecif
region
see
tabl
provid
inform
probe
primer
today
whole
genom
mani
pathogen
sequenc
inform
avail
databas
sequenc
tradit
phenotyp
method
detect
pathogen
well
tri
rel
cheap
avail
hospit
privat
patholog
laboratori
tabl
howev
util
need
consid
context
direct
visualis
cultur
alway
feasibl
techniqu
time
consum
technic
difficult
phenotyp
variat
occur
pathogen
life
cycl
eg
egg
larva
adult
form
speci
may
alter
depend
stage
develop
associ
host
vector
whether
organ
freeliv
thu
antibodi
isoenzym
techniqu
detect
may
becom
limit
depend
stage
life
cycl
host
immun
respons
delay
convers
remain
persist
even
resolut
previou
infect
crossreact
antibodi
acquir
natur
infect
vaccin
produc
fals
posit
result
phenotyp
method
use
discrimin
isol
genera
speci
approach
less
effect
come
distinguish
differ
within
speci
recent
emerg
synthesis
pcr
dna
probe
isol
synthesis
oligonucleotid
probe
nucleic
acid
hybridis
techniqu
ribotyp
use
target
probe
repetit
dna
exampl
ribosom
rna
rrna
rrna
rrna
gene
chromosom
dna
provid
natur
deriv
amplifi
product
enhanc
hybridis
potenti
circumst
radiolabel
dna
probe
avoid
sinc
signaltonois
ratio
increas
amplifi
target
sequenc
figur
method
differenti
bacteria
call
ribotyp
ribotyp
dna
broken
fragment
use
restrict
endonucleas
dna
probe
specif
rrna
gene
allow
variou
fragment
identifi
compar
approach
similar
dna
map
southern
blot
eukaryot
dna
see
appendix
bacteri
hybridis
pattern
compar
eukaryot
dna
polymorph
puls
field
gel
electrophoresi
pfge
type
dna
electrophoresi
capabl
separ
larg
dna
fragment
fragment
result
digest
organ
genom
restrict
endonucleas
enzym
noti
cut
dna
infrequ
see
tabl
pattern
fragment
gener
way
suffici
discriminatori
allow
bacteri
strain
distinguish
read
pfge
legionella
dna
hybridis
rrna
rrna
contain
highli
conserv
region
common
bacteria
well
highli
variabl
region
uniqu
particular
speci
therefor
multifunct
dna
rna
probe
prepar
sinc
gener
bacteria
specif
differ
speci
strain
reason
say
whatev
done
variou
dna
probe
hybridis
techniqu
describ
also
accomplish
probabl
better
pcr
thu
genusspecif
speciesspecif
pcrbase
assay
mani
strategi
appropri
rang
activ
involv
microorgan
environ
food
industri
research
clinic
practic
ultim
inform
obtain
microorgan
dna
sequenc
genom
increasingli
possibl
consequ
human
genom
project
sequenc
mani
model
stain
visual
identif
characterist
coloni
size
shape
colour
give
clue
underli
organ
nake
eye
microscop
use
light
microscopi
stain
eg
gram
stain
rapid
approach
identifi
light
electron
mani
bacteria
virus
visibl
electron
microscop
cultur
growth
organ
display
cultur
growth
characterist
eg
tuberculosi
slow
grower
organ
distinguish
growth
particular
media
eg
chocol
agar
need
fastidi
grower
h
influenza
presenc
catalas
degrad
hydrogen
peroxid
use
differenti
mani
gram
posit
organ
immunolog
ie
recognit
antiserum
use
agglutin
salmonella
shigella
speci
antibodi
produc
antigen
determin
relat
patient
use
identifi
activ
past
infect
organ
host
specif
immun
respons
product
antibodi
plasmid
dna
rrna
nuclear
dna
fig
potenti
target
nucleic
acid
dna
rna
probe
pathogen
detect
nuclear
dna
rna
rrna
ribosom
rna
ubiquit
stabl
provid
use
target
wide
rang
hybridis
pcrbase
assay
plasmid
dna
present
multipl
copi
although
lost
undergo
rearrang
therefor
plasmid
dna
depend
target
test
provid
inform
infect
antibiot
resist
nuclear
rrna
probe
provid
widerang
genotyp
assay
extend
across
entir
taxonom
spectrum
famili
genu
speci
strain
organ
see
tabl
spread
epidem
hospitalacquir
nosocomi
infect
follow
characteris
accuraci
identif
uniqu
dna
fingerprint
individu
pathogen
valu
dna
approach
emerg
infect
recent
illustr
sar
sever
acut
respiratori
syndromediscuss
detail
realtim
pcr
start
make
signific
impact
molecular
microbiolog
techniqu
particularli
valuabl
risk
contamin
reduc
realtim
pcr
conduct
close
systemse
chapter
appendix
result
realtim
pcr
quickli
avail
semiautom
possibl
essenti
deal
common
infect
number
refer
specimen
would
high
relat
realtim
pcr
quantit
pcr
qpcr
techniqu
essenti
accur
viral
quantit
hiv
hcv
number
paramet
use
assess
valu
diagnost
test
sensit
refer
percentag
true
posit
detect
posit
testor
probabl
test
posit
diseas
present
specif
refer
percentag
true
neg
detect
neg
testor
probabl
test
neg
diseas
present
tabl
paramet
larg
product
test
alter
accord
popul
test
howev
alway
directli
demonstr
test
use
better
assess
predict
valu
posit
predict
valu
neg
result
come
test
posit
predict
valu
ppv
refer
percentag
posit
test
result
truli
posit
probabl
diseas
present
test
posit
ppv
influenc
specif
also
preval
test
popul
higher
preval
higher
ppv
sinc
less
chanc
fals
posit
result
neg
predict
valu
npv
refer
percentag
neg
test
result
truli
neg
probabl
diseas
absent
test
neg
npv
influenc
test
sensit
well
preval
high
npv
easier
obtain
infect
low
preval
popul
test
high
ppv
requir
condit
fals
diagnosi
signific
consequ
eg
treatment
regimen
potenti
toxic
medic
psycholog
stigmata
associ
po
date
dna
test
microbiolog
direct
predominantli
detect
organ
difficult
cultur
vitro
variou
reason
delay
transport
low
titr
pathogen
prior
treatment
antibiot
growth
unlik
infect
mix
pathogen
might
also
use
approach
dna
analysi
apart
straightforward
diagnost
applic
dna
microbiolog
test
use
detect
antimicrobi
resist
methicillinresist
aureu
vancomycinresist
enterococci
spp
toxigen
form
e
coli
recent
avail
dna
technolog
quantit
hcv
hiv
use
plan
monitor
treatment
tabl
provid
scenario
involv
dna
test
unlik
molecular
genet
dna
test
commerci
produc
kit
made
earli
entri
molecular
microbiolog
allow
wider
rang
laboratori
particip
technolog
import
boost
area
human
genom
project
chapter
success
complet
genom
sequenc
number
microorgan
catalyst
human
sequenc
endeavour
well
characteris
genom
addit
model
organ
next
develop
major
impact
molecular
microbiolog
microarray
see
chapter
appendix
nanotechnolog
chapter
latter
enhanc
potenti
point
care
test
contrast
genet
dna
laboratori
microbiolog
dna
laboratori
face
greater
technic
challeng
infect
sampl
invari
littl
pathogen
dna
function
templat
pcr
limit
amount
dna
avail
mix
dna
mani
organ
present
small
target
pcr
surpris
contamin
pcr
product
sampl
previou
amplif
becom
major
sourc
error
anoth
inher
problem
microbiolog
set
potenti
inhibitor
variou
sampl
test
interfer
dna
amplif
final
interpret
microbiolog
dna
result
difficult
test
show
presenc
pathogen
dna
whether
indic
activ
tuberculosi
fastidi
grower
cultur
pcr
demonstr
high
sensit
particularli
use
rapid
still
play
import
role
specif
specimen
diagnosi
essenti
eg
tb
overal
manag
remain
acid
faststain
bacteria
mening
gold
standard
way
detect
measur
drug
sensit
difficult
detect
pcr
detect
viru
csf
avoid
need
brain
biopsi
convent
assay
scenario
enceph
detect
swab
cultur
pcrbase
method
rapid
earli
detect
possibl
possibl
easier
hiv
hcv
quantit
pcr
quantit
avail
drug
treatment
aid
convent
assay
commerci
kit
monitor
cell
count
viral
load
aureu
methicillin
cultur
sensit
test
pcrbase
assay
target
variou
inform
becom
enteroccoci
spp
possibl
take
antibiot
drugresist
gene
avail
genom
vancomycin
day
complet
hour
pathogen
possibl
tuberculosi
variou
drug
test
variou
dna
marker
hsv
acyclovir
cmv
predict
pathogen
effect
ganciclovir
infect
residu
dna
pathogen
die
determin
hand
find
mrna
ie
cdna
pcr
like
indic
activ
infect
one
add
dna
test
rel
expens
compar
tradit
approach
surpris
mani
optimist
predict
molecular
microbiolog
slow
materialis
howev
steadili
grow
accept
dna
diagnost
threat
bioterror
emerg
global
infect
fear
sar
best
resolv
dna
rna
compon
part
overal
contain
strategi
decemb
estim
million
peopl
infect
hiv
million
die
aid
includ
number
million
children
year
age
million
hivinfect
women
give
birth
year
http
wwwwhointwhr
region
world
aid
includ
africa
asia
latin
america
north
america
europ
caribbean
oceania
three
quarter
case
found
subsaharan
africa
worri
trend
occur
india
estim
hiv
infect
somewher
million
peopl
two
viral
type
first
isol
figur
year
later
similar
viru
found
pari
west
african
patient
aid
seroneg
predominantli
found
number
west
african
countri
includ
seneg
ivori
coast
gambia
ghana
nigeria
spread
countri
histor
link
african
sourc
ie
franc
portug
angola
mozambiqu
howev
eas
air
travel
sporad
case
appear
countri
overal
spread
less
rapidli
take
longer
top
schemat
represent
hiv
genom
famili
retrovirida
genu
lentiviru
show
compris
two
ident
strand
rna
within
core
viral
protein
key
viral
enzym
revers
transcriptas
viral
dna
synthesi
integras
integr
host
cell
chromosom
proteas
viral
assembl
core
surround
protect
envelop
env
deriv
viral
glycoprotein
membran
previou
host
cell
compon
envelop
transmembran
protein
surfac
protein
abbrevi
molecular
weight
molecular
weight
bottom
number
gene
make
hiv
gag
group
specif
antigen
code
capsid
matrix
nucleocapsid
protein
pol
code
revers
transcriptas
proteas
integras
ribonucleas
env
envelop
code
glycoprotein
precursor
cleav
give
envelop
structur
protein
although
rna
viru
hiv
abl
produc
dna
revers
transcriptas
enzym
infect
cell
viral
dna
integr
via
integras
doublestrand
host
dna
produc
provir
form
shown
six
regulatori
gene
rev
tat
nef
vpr
vpu
vif
give
hiv
complex
structur
compar
anim
retrovirus
ltrlong
termin
repeat
retroviru
develop
lower
viral
load
associ
may
also
explain
less
like
transmit
mother
babi
retrovirus
call
transfer
order
inform
rna
dna
belong
lentiviru
genu
predominantli
affect
nervou
immun
system
transmiss
occur
one
three
rout
sexuallyboth
male
male
male
femal
blood
blood
product
includ
hivcontamin
needl
perinatallydur
birth
breast
feed
present
effect
vaccin
aid
perinat
transmiss
reduc
treat
mother
antiretrovir
agent
avoid
breast
feed
earli
wean
prevent
also
possibl
screen
blood
discuss
practic
safe
sex
treatment
option
dramat
improv
outlook
aid
howev
less
requir
treatment
develop
countri
access
antiretrovir
drug
box
urgenc
potenti
implic
aid
pandem
result
mani
research
program
direct
better
diagnost
test
effect
therapeut
regimen
greater
understand
viral
biolog
identif
hiv
virus
requir
extens
chang
made
blood
screen
protocol
see
area
rdna
technolog
play
major
role
context
present
theme
laboratori
detect
molecular
medicin
import
function
play
sinc
opportunist
infect
chief
caus
death
aid
aid
develop
infect
time
ill
pathogen
involv
includ
normal
produc
overt
diseas
candida
albican
exot
organ
usual
seen
clinic
practic
eg
jc
viru
give
rise
demyelin
neurolog
disord
call
progress
multifoc
leukoencephalopathi
circumst
standard
microbiolog
detect
method
often
prove
ineffect
mani
commerci
elisa
enzym
link
immunosorb
assay
kit
detect
antibodi
figur
use
screen
risk
blood
donor
assay
well
standardis
good
sensit
specif
hiv
infect
screen
test
must
highest
sensit
posit
miss
fals
posit
exclud
use
second
assay
high
specif
eg
western
blot
test
dna
analysi
direct
toward
gag
env
pol
gene
viru
see
figur
laboratori
techniqu
detect
strategi
algorithm
utilis
sequenc
construct
aid
repres
clinic
phase
hiv
infect
well
establish
therefor
effect
treatment
must
start
earli
take
consider
featur
infectionth
rapid
develop
mutant
virus
occur
hiv
infect
associ
signific
viraemia
viral
popul
heterogen
due
errorpron
revers
transcriptas
unlik
dna
polymeras
make
mistak
replic
dna
therefor
mutat
constantli
produc
hiv
gene
mutant
virus
form
combin
high
viral
titr
present
facilit
develop
resist
key
success
aid
treatment
haart
highli
activ
antiretrovir
therapi
becam
avail
involv
use
multipl
drug
direct
differ
viral
pathway
combin
drug
therapi
involv
use
three
drug
synergist
rather
addit
effect
reduc
viral
load
delay
develop
drug
resist
variou
combin
use
exampl
two
nucleosid
nucleotid
analogu
third
drug
nonnucleosid
revers
transcriptas
inhibitor
proteas
inhibitor
recent
fourth
class
drug
complet
new
mechan
action
develop
involv
inhibit
entri
lymphocyt
major
question
requir
resolut
includ
start
haart
optim
drug
combin
drug
approv
fda
treat
hiv
infect
despit
use
haart
hiv
reemerg
therapi
stop
indic
virostat
rather
virocid
effect
better
drug
still
need
importantli
vaccin
allow
prevent
hivaid
optimis
sensit
specif
minimis
fals
posit
fals
neg
result
estim
one
provir
copi
detect
background
mononuclear
cell
peripher
blood
viru
isol
method
compar
sensit
although
variou
problem
test
exclud
routin
assay
variat
pcr
techniqu
includ
nest
pcr
see
chapter
appendix
use
reduc
fals
posit
rate
due
case
contamin
sampl
reagent
hand
fals
neg
result
reflect
presenc
inhibitor
specimen
test
chemic
substanc
anticoagul
anoth
sourc
fals
neg
result
hiv
occur
consider
divers
found
viral
dna
sequenc
mismatch
usual
primer
pair
inhibit
subsequ
pcr
step
difficulti
avoid
use
primer
pair
combin
deriv
conserv
segment
viral
genom
present
serolog
test
remain
prefer
screen
method
atrisk
individu
includ
blood
donor
fast
rel
cheap
abl
autom
see
also
blood
screen
number
import
recent
virus
reach
notorieti
associ
blood
transfus
previous
blood
transfus
servic
base
donor
blood
screen
program
detect
antibodi
antigen
donor
blood
suppli
howev
approach
shown
inadequ
import
new
addit
screen
protocol
use
pcr
identifi
viral
dna
rna
advantag
nat
assay
includ
higher
sensit
greater
reliabl
window
period
time
blood
donor
becom
infecti
donor
screen
test
becom
posit
ie
seroconvers
occur
pcrbase
assay
screen
blood
donat
use
test
pool
donat
exampl
donat
simultan
individu
donat
former
rapid
cheaper
rare
case
hiv
hepat
c
viru
hcv
miss
mean
test
individu
donat
method
choic
screen
nat
number
potenti
drawback
includ
involv
sophist
technolog
therefor
train
staff
need
test
elisa
test
mainstay
routin
hiv
detect
rapid
abl
test
mani
sampl
disadvantag
fals
posit
fals
neg
confirm
western
blot
second
elisa
immunofluoresc
test
essenti
apart
technic
cleric
mistak
lead
fals
neg
result
common
reason
type
error
window
period
sinc
take
week
infect
antibodi
form
second
independ
sampl
test
reduc
potenti
technic
cleric
problem
definit
diagnosi
made
quantit
pcr
qpcr
use
assess
viral
load
help
decid
start
therapi
use
monitor
respons
therapi
invari
expens
assay
technic
demand
includ
strict
requir
prevent
contamin
result
nat
take
longer
serolog
elisa
enzym
link
immunosorb
assay
howev
respons
number
case
contamin
blood
mani
blood
transfus
servic
opt
nat
test
blood
transfus
servic
screen
blood
donor
rang
infecti
agent
eg
hepat
b
viru
hbv
hcv
region
human
tcell
lymphotrop
viru
type
ii
htlvi
htlvii
syphili
cytomegaloviru
cmv
recent
west
nile
viru
usa
screen
test
undertaken
select
circumst
eg
cmvfree
blood
requir
immunosuppress
patient
fetu
neonat
risk
bloodborn
viral
infect
dramat
decreas
implement
donor
questionnair
allow
selfexclus
particularli
import
infect
routin
test
donor
blood
test
elisa
pcrbase
techniqu
latter
sensit
sever
magnitud
higher
cultur
elisa
method
exclud
potenti
slow
viru
transmiss
ie
cjd
vcjd
blood
transfus
servic
defer
use
donor
live
uk
certain
time
period
tabl
reason
deferr
includ
fever
headach
week
donat
possibl
west
nile
viru
other
travel
risk
region
exampl
possibl
malaria
apart
hiv
anoth
success
blood
transfus
screen
hcv
sinc
singlestrand
kb
rna
sequenc
hcv
report
possibl
use
enzym
immunoassay
detect
antibodi
number
viral
antigen
patient
test
blood
donor
screen
howev
firstgener
immunoassay
gave
rise
mani
fals
posit
problem
serolog
test
overcom
avail
sophist
secondand
thirdgener
enzym
immunoassay
similar
happen
hiv
resolut
fals
posit
result
undertaken
addit
assay
immunoblot
incorpor
multipl
viralspecif
antigen
viral
antigen
mani
modern
test
prepar
use
rdna
express
system
e
coli
yeast
see
chapter
indetermin
equivoc
result
evalu
pcr
start
risk
blood
transfusionacquir
hiv
postnat
era
donor
blood
fullrang
seriou
consequ
bloodborn
hcv
infect
howev
follow
test
includ
nat
test
protocol
hcv
rare
complic
risk
blood
transfusionacquir
hcv
postnat
era
donor
blood
thirdrisk
blood
transfusionacquir
hbv
still
rel
high
although
gener
serolog
assay
posttransfus
hepat
due
hbv
unlik
hcv
risk
hepat
b
surfac
antigen
chronic
liver
diseas
less
hbv
questionnair
histori
fever
headach
week
donat
ye
answer
lead
deferr
worthwhil
compar
infecti
risk
blood
transfus
incompat
blood
transfus
associ
mortal
fda
report
twice
frequenc
incompat
blood
transfus
compar
infect
uk
advers
event
relat
incompat
blood
transfus
time
higher
infecti
diseas
pathogenesi
mani
infect
particularli
viral
one
deduc
experiment
strategi
base
light
electron
microscopi
cell
cultur
immunoassay
research
tool
ad
nucleic
acid
dna
rna
probe
situ
hybridis
nat
advantag
provid
dna
techniqu
includ
abil
detect
latent
nonrepl
virus
localis
genom
nuclear
cytoplasm
region
within
cell
tissu
integr
remain
preserv
situ
hybridis
histolog
evalu
also
undertaken
nucleic
acid
probe
techniqu
nat
manipul
enabl
broad
spectrum
serotyp
detect
particularli
valuabl
emerg
infect
underli
serotyp
unknown
recent
power
applic
dna
techniqu
abil
sequenc
whole
genom
identifi
pathogen
genom
sequenc
predict
role
diseas
pathogenesi
identifi
region
genom
suitabl
natbas
detect
method
host
respons
infect
involv
complex
mix
genet
environment
factor
human
evid
genet
compon
contribut
outcom
infecti
diseas
come
observ
ethnic
group
resist
infect
wherea
other
appear
increas
suscept
eg
resist
malaria
black
african
suscept
chronic
carrier
state
hbv
chines
expos
get
infect
progress
aid
show
differ
respons
exampl
rapid
progress
within
year
individu
demonstr
benign
progress
extend
year
host
resist
like
repres
multipl
genet
effectsi
qtl
quantit
trait
loci
interact
environmentthey
difficult
detect
sought
usual
molecular
genet
approach
particularli
associ
case
control
studi
investig
candid
gene
see
chapter
discuss
strategi
qtl
target
macrophag
monocyt
lymphocyt
carri
cell
surfac
protein
first
attach
chemokin
receptor
occur
hiv
protein
penetr
cell
membran
enabl
hiv
infect
cell
circumst
particularli
diseas
progress
mutat
env
gene
enabl
move
away
receptor
receptor
therefor
two
hostrel
genet
factor
influenc
infect
human
chemokin
receptor
gene
major
histocompat
complex
mhc
chemokin
function
coreceptor
requir
hiv
enter
cell
highli
polymorph
variant
found
differ
ethnic
group
one
import
variant
involv
bp
delet
code
region
lead
truncat
protein
known
homozygot
approxim
caucasian
signific
resist
hiv
infect
viru
lost
one
entri
point
cell
heterozygot
appear
enhanc
resist
hiv
infect
although
progress
clinic
aid
delay
viral
load
lower
genet
variant
relat
report
influenc
hiv
infect
progress
tabl
second
probabl
import
genet
factor
influenc
hiv
infect
came
observ
appar
hivresist
femal
sex
defect
decreas
amount
receptor
homozygot
strong
resist
hiv
infect
although
absolut
progress
aid
slow
heterozygot
apart
bp
defect
mutat
promot
also
associ
increas
gene
function
therebi
acceler
develop
aid
mutat
promot
affect
ligand
suscept
well
hiv
progress
depend
rant
express
affect
variant
appear
delay
progress
hiv
perhap
impair
transit
receptor
altern
one
variant
end
appear
impair
hiv
entri
cell
perhap
transit
unlik
protect
effect
defect
controversi
role
play
genet
variat
identifi
genet
associ
studi
b
two
import
gene
influenc
progress
hiv
aid
ifng
gene
produc
cytokin
inhibit
hiv
replic
henc
genet
variant
lead
overexpress
gene
favour
milder
diseas
convers
occur
genet
variant
associ
reduc
express
worker
nairobi
women
shown
particular
hla
type
hla
hla
propos
enhanc
resist
better
present
hiv
antigen
lymphocyt
therefor
viru
rapidli
clear
immun
system
subsequ
mani
associ
describ
hla
type
increas
resist
greater
suscept
hiv
infect
progress
aid
tabl
anoth
observ
involv
hla
mother
children
mismatch
mhc
less
like
perinat
transmiss
immun
surveil
enhanc
howev
hla
protect
effect
observ
hiv
acquir
breast
feed
hla
associ
aid
well
infect
report
includ
polymorph
interleukin
tabl
like
associ
studi
genet
disord
report
produc
mani
correl
genet
marker
respons
infect
although
often
remain
controversi
confus
found
associ
studi
well
demonstr
hcv
exampl
tabl
year
million
case
falciparum
malaria
africa
around
million
death
result
resurg
malaria
reflect
socioeconom
factor
poverti
overcrowd
emerg
mosquito
resist
insecticid
develop
drug
resist
two
common
form
malaria
p
falciparum
p
vivax
produc
sever
anaemia
addit
p
falciparum
associ
cerebr
malaria
respiratori
metabol
complic
differ
spectrum
partli
explain
p
falciparum
abl
invad
larg
proport
red
cell
initi
cytotox
cell
hla
b
c
pathogen
eg
virus
respons
class
ii
express
antigenfrom
extracellular
intravesicular
cell
lead
cytokin
product
hla
dp
dq
dr
present
cell
ie
pathogen
eg
bacteria
fungi
promot
b
cell
antibodi
product
macrophag
dendrit
cell
phase
viral
infect
b
lymphocyt
mhc
human
usual
call
hla
locu
code
cell
surfac
protein
import
immun
surveil
sinc
cell
respond
foreign
peptid
pathogen
unless
coat
present
mhc
protein
blood
cell
compar
p
vivax
invad
reticulocyt
anoth
explan
mode
entri
parasit
red
blood
cell
p
falciparum
number
differ
invas
pathway
compar
p
vivax
abl
enter
red
blood
cell
carri
duffi
blood
group
host
factor
provid
protect
malaria
identifi
includ
singl
gene
effect
seen
haemoglobinopathi
sickl
cell
anaemia
thalassaemia
duffi
neg
blood
group
former
explain
suboptim
red
blood
cell
environ
provid
good
milieu
parasit
duffi
neg
blood
group
power
protect
effect
sinc
receptor
p
vivax
enter
red
blood
cell
thu
p
vivax
seen
west
africa
popul
duffi
neg
although
vaccin
hbv
made
signific
reduct
new
case
worldwid
still
remain
million
infect
individu
longterm
complic
dna
viru
occur
infect
includ
chronic
hepat
cirrhosi
hepatocellular
carcinoma
go
develop
chronic
carrier
state
known
cours
ill
infect
variabl
explain
basi
involv
viral
genotyp
host
immun
respons
ie
follow
acut
infect
vigor
cell
respons
variou
viralspecif
compon
core
envelop
polymeras
limit
infect
contrast
poor
cellular
immun
respons
like
develop
chronic
carrier
state
scenario
mhc
play
key
role
sinc
class
ii
molecul
hla
complex
critic
cell
function
evid
mhcrelat
effect
hepat
b
infect
present
tabl
polygen
trait
contribut
pathogen
suscept
resist
human
would
difficult
separ
individu
compon
genet
variabl
human
genom
howev
overcom
use
differ
strain
inbr
anim
particularli
mice
sinc
chromosom
segment
mous
trace
homolog
synten
region
human
becom
possibl
identifi
genet
locu
gene
mous
go
back
correspond
region
human
genom
find
equival
gene
forward
genet
screen
phenotyp
genotyp
result
observ
particular
mous
strain
one
creat
exampl
chemic
mutagen
enuchapt
phenotyp
alter
anim
expect
respons
infect
exampl
would
mous
strain
shown
resist
leishmania
donovani
infect
observ
gene
isol
convent
posit
clone
gene
call
renam
mice
mutat
gene
particularli
resist
three
intracellular
pathogen
mycobacterium
bovi
salmonella
typhimurium
leishmania
donovani
gene
like
play
key
role
infect
sinc
exclus
express
macrophag
key
cell
control
three
intracellular
pathogen
mention
revers
genet
screen
genotyp
phenotyp
exemplifi
transgen
knockout
mous
particular
phenotyp
associ
gene
confirm
inactiv
gene
one
interest
knockout
involv
remov
tnfa
tumour
necrosi
factor
gene
lead
mous
suscept
pathogen
tuberculosi
l
monocytogen
similar
suscept
seen
mous
interferong
gene
knock
gene
play
key
role
immun
respons
anoth
strategi
allow
mous
model
use
infect
found
exclus
human
humanis
mous
particular
hosttrop
explain
speci
specif
exampl
polio
viru
normal
infect
mice
howev
transgen
mice
express
human
polioviru
receptor
develop
polio
infect
intracerebr
infect
oral
addit
creat
suitabl
anim
model
experi
also
indic
oral
phase
infect
polioviru
like
involv
anoth
receptor
resist
antibiot
alway
concern
howev
new
antibiot
temporarili
address
problem
fals
sens
secur
reinforc
next
two
decad
newer
power
antibiot
today
increas
trend
antibiot
resist
alarm
match
new
drug
develop
led
world
health
organ
develop
plan
address
becom
global
problem
resist
antibiot
occur
three
major
mechan
reduc
antibiot
uptak
cell
increas
efflux
cell
modif
inactiv
antibiot
alter
target
antibiot
develop
resist
may
intrins
featur
organ
may
result
mutat
acquisit
resist
gene
transfer
resist
gene
occur
via
plasmid
tran
poson
latter
repres
mobil
dna
element
move
plasmid
plasmid
chromosom
thu
potenti
dissemin
wide
stabli
drug
resist
gene
gene
involv
antibiot
resist
characteris
enabl
better
understand
develop
detect
quickli
dnabas
approach
final
identifi
strategi
resist
pathway
bypass
apart
inappropri
use
antibiot
medicin
agricultur
anim
feed
antibiot
use
beef
poultri
industri
contribut
increas
resist
factor
involv
includ
travel
tourism
pneumococci
import
pathogen
commun
lead
central
nervou
system
infect
pneumonia
otiti
media
children
resist
macrolid
antibiot
eg
erythromycin
countri
reach
alarm
proport
exampl
streptococcu
pneumonia
resist
erythromycin
part
asia
two
major
mechan
explain
resist
organ
bacteria
carri
ermb
gene
methyl
specif
amino
acid
ribosom
site
action
macrolid
interfer
bind
antibiot
region
bacteria
carri
mefa
gene
efflux
pump
gene
export
antibiot
protect
ribosom
multidrug
resist
mdr
occur
antibiot
anticanc
agent
refer
develop
resist
rang
drug
may
unrel
differ
wide
structur
target
common
pathway
seen
mdr
one
involv
pglycoprotein
gene
plasma
membranespan
multidrug
transport
protein
one
import
mechan
mdr
abil
extrud
antibiot
anticanc
drug
cell
figur
antibiot
resist
mani
gram
neg
bacteria
pseudomona
aeruginosa
acinetobact
spp
enterobacteriacea
occur
effluxmedi
mechan
rifampicin
occupi
pivot
place
world
health
organ
multidrug
resist
program
tuberculosi
tb
leprosi
despit
new
tb
case
caus
multidrugresist
strain
develop
resist
major
therapeut
public
health
implic
sinc
lepra
grow
slowli
essenti
confirm
develop
drug
resist
altern
mean
tradit
cultur
approach
similarli
avoid
use
ineffect
drug
cost
consider
well
way
optimis
antimicrobi
therapi
center
diseas
control
recommend
resist
pattern
tb
report
within
day
specimen
receiv
howev
challeng
slowgrow
tuberculosi
therefor
altern
approach
use
molecular
diagnost
techniqu
identifi
resist
gene
mycobacteria
recent
use
variou
drug
combin
select
isoniazid
rifampicin
ethambutol
streptomycin
pyrazinamid
well
improv
live
standard
instrument
produc
declin
incid
tuberculosi
howev
chang
number
new
case
increas
tradit
dogma
activ
case
usual
aris
infect
acquir
year
earlier
longer
applic
sinc
dna
studi
shown
approxim
one
third
activ
case
citi
result
persontoperson
transmiss
contribut
factor
two
major
class
describ
first
abc
atp
bind
cassett
transport
utilis
atp
transport
drug
cell
class
mostli
found
eukaryot
cell
would
predominantli
involv
resist
develop
cancer
drug
although
also
implic
drug
resist
wide
rang
pathogen
second
includ
number
famili
mf
smr
mate
rnd
move
drug
cell
time
move
proton
sodium
member
class
found
predomin
prokaryot
would
import
antibiot
resist
increas
tuberculosi
find
multidrugresist
strain
hiv
infect
intraven
drug
use
declin
live
standard
result
polit
chang
war
molecular
level
gene
associ
drug
resist
defin
tabl
deal
challeng
modern
global
strategi
direct
tuberculosi
leprosi
requir
laboratori
facil
utilis
stateoftheart
technolog
provid
health
profession
accur
inform
effici
time
fashion
latter
half
twentieth
centuri
chloroquin
drug
choic
treat
falciparum
malaria
howev
spread
drugresist
plasmodium
falciparum
lesser
extent
plasmodium
vivax
made
prophylaxi
treatment
malaria
global
public
health
issu
chloroquineresist
p
falciparum
present
everi
major
region
malaria
endem
air
travel
mean
drugresist
strain
appear
citi
resist
spread
sinc
limit
number
foci
south
east
asia
south
america
epidemiolog
consist
multigen
effect
ie
rare
event
occur
initi
south
east
asia
south
america
spread
slowli
worldwid
contrast
resist
pyrimethamin
proguanil
arisen
independ
mani
differ
region
drug
use
consist
singl
gene
involv
molecular
basi
resist
malaria
slowli
unravel
mani
gene
implic
tabl
molecular
defect
becom
comprehens
characteris
possibl
predict
drug
resist
pattern
variou
geograph
region
optimis
drug
select
might
also
feasibl
use
drug
geneticbas
therapi
bypass
resist
defect
parasit
allow
continu
use
costeffect
rel
safe
drug
chloroquin
anoth
posit
develop
therapi
malaria
avail
dna
sequenc
genom
import
human
mous
malaria
parasit
develop
enabl
new
target
found
ie
gene
metabol
pathway
differ
parasit
human
monitor
respons
aid
drug
treatment
undertaken
measur
cell
count
well
assess
viral
load
qpcr
usa
half
patient
infect
virus
resist
drug
mutat
caus
resist
well
like
mode
action
well
understood
hiv
includ
mani
singl
base
chang
occasion
insert
amino
acid
cross
resist
occur
restrict
drug
within
class
although
class
drug
develop
resist
tend
occur
slowli
period
time
box
describ
variou
drug
resist
result
mani
mutat
accumul
within
hiv
although
one
except
mutat
revers
transcriptas
alon
produc
complet
resist
lamivudin
plasma
viral
load
rise
despit
therapi
chang
regimen
need
involv
least
four
differ
genet
loci
katg
inha
ahpc
oxyr
gene
affect
differ
metabol
pathway
one
particular
mutat
frequent
associ
highlevel
resist
mutat
found
embcab
gene
involv
metabol
pathway
streptomycin
mutat
found
rr
code
rna
rpsl
code
ribosom
protein
despit
mani
resistancerel
mutat
identifi
resist
strain
tuberculosi
mutat
gene
group
streptococcu
ga
respons
wide
rang
human
infect
virul
factor
organ
produc
broad
spectrum
toxic
effect
antiphagocyt
cellular
adher
internalis
invas
system
toxic
import
toxin
associ
ga
better
understood
analysi
gene
b
haemolysin
effect
difficult
studi
without
dna
technolog
b
haemolysin
effect
ga
due
power
cytotoxin
call
streptolysin
broad
toxic
effect
cell
nonimmunogen
gene
streptolysin
isol
call
sag
compris
differ
contigu
gene
saga
sagi
correspond
gene
b
haemolysin
group
b
streptococci
cyl
involv
contigu
gene
h
pylori
import
gram
neg
slowgrow
bacterium
colonis
gastric
epithelium
lead
chronic
gastriti
ulcer
cancer
infect
strongli
associ
socioeconom
statu
preval
develop
countri
much
lower
one
affluent
region
diseas
outcom
depend
number
factor
includ
bacteri
genotyp
infect
h
pylori
treat
antibiot
howev
common
commun
vaccin
approach
prevent
would
econom
effect
identifi
potenti
target
vaccin
organ
variou
virul
factor
identifi
includ
ureas
vacuol
toxin
cytotoxin
adher
factor
genom
bacterium
sequenc
possibl
understand
better
bacterium
acid
toler
gene
involv
pathogenesi
number
virulenceproduc
gene
characteris
includ
vacaexotoxinproduc
vacuol
epitheli
cell
associ
greater
risk
ulcer
cag
pai
region
associ
induct
intens
host
inflammatori
respons
lead
sever
diseas
western
popul
signific
cag
pai
develop
world
less
obviou
almost
strain
cag
posit
dna
rna
virus
caus
tumour
human
oncogen
virus
includ
hepat
b
dna
hepat
c
rna
hepatocellular
carcinoma
papillomaviru
dna
cervic
cancer
epsteinbarr
viru
ebv
dna
viru
associ
develop
lymphoid
epitheli
tumour
hepat
b
viru
hepatotrop
dna
viru
replic
cycl
within
liver
nucleu
lead
format
matur
virion
via
revers
transcriptas
export
cell
altern
newli
form
viral
dna
recycl
back
nucleu
convers
plasmid
form
gener
genom
transcript
maintain
constant
intranuclear
pool
templat
transcript
hbv
replic
cycl
within
hepatocyt
directli
respons
liver
damag
consist
observ
mani
hbv
carrier
asymptomat
minim
liver
damag
also
observ
immun
defect
tend
chronic
carrier
hbv
usual
associ
mild
liver
damag
therefor
propos
liver
damag
follow
chronic
hbv
infect
predominantli
result
host
immun
respons
particular
cytotox
cell
natur
killer
cell
inflammatori
product
includ
tumour
necrosi
factor
tnf
free
radic
proteas
primari
hbv
infect
adult
selflimit
compar
hepat
c
viru
discuss
futur
primari
infect
adult
continu
lead
persist
infect
estim
million
peopl
worldwid
hbv
carrier
chronic
carrier
go
develop
seriou
complic
cirrhosi
liver
transplant
hbv
associ
recurr
infect
patient
unless
prevent
measur
undertaken
reduc
risk
reinfect
includ
use
hepat
b
immun
globulin
antivir
agent
lamivudin
also
use
treat
aid
see
box
anoth
seriou
consequ
chronic
hbv
infect
hepatocellular
carcinoma
carrier
time
like
develop
noncarri
hbeag
posit
carrier
particularli
risk
surpris
sinc
serolog
marker
associ
high
hbv
titr
despit
hbv
genom
sequenc
characteris
disappoint
even
today
incomplet
understand
dna
viru
lead
develop
hepatocellular
carcinoma
papillomavirus
dna
virus
exhibit
speci
specif
induc
hyperplast
epitheli
lesion
result
infect
cervic
cancer
second
common
cancer
women
worldwid
unequivoc
evid
implic
certain
type
human
papillomaviru
hpv
primari
caus
cervic
cancer
precursor
cervic
intraepitheli
neoplasia
hpv
acquir
mainli
sexual
activ
type
hpv
identifi
infect
genit
tract
cervic
cancer
begin
preinvas
neoplast
chang
cell
histolog
describ
cincerv
intraepitheli
neoplasia
may
regress
remain
unchang
progress
invas
malign
human
papillomaviru
implic
variou
stage
cervic
cancer
differ
type
correl
histolog
find
human
papillomaviru
recent
implic
anal
cancer
particularli
hiv
posit
penil
laryng
oral
cancer
human
papillomavirusrel
skin
cancer
found
immunosuppress
human
papillomavirus
induc
cellular
transform
may
also
interact
virus
oncogen
carcinogen
bring
neoplast
chang
viru
sole
factor
progress
invas
cervic
cancer
figur
oncoprotein
code
protein
essenti
viral
replic
hpv
type
bind
inactiv
therebi
disrupt
key
cell
cycl
checkpoint
see
figur
oncoprotein
bind
inactiv
retinoblastoma
gene
product
lead
uncontrol
cell
cycl
progress
variou
type
human
papillomavirus
distinguish
basi
dna
sequenc
comparison
histolog
find
viral
type
enabl
classif
three
groupslow
intermedi
high
risk
tabl
commerci
kit
base
pcr
assay
avail
identifi
highrisk
hpv
test
consid
sensit
howev
mention
previous
dna
test
indic
presenc
viral
dna
predict
whether
infect
activ
transient
henc
suggest
hpv
dna
test
would
replac
tradit
papanicola
smear
incorrect
particularli
young
women
like
transient
hpv
infect
howev
use
conjunct
papanicola
smear
papillomaviru
dna
screen
help
suspici
result
combin
might
becom
prefer
method
screen
women
year
age
way
combin
test
increas
overal
sensit
screen
increas
interv
test
ebv
ubiquit
human
herp
viru
infect
adult
infect
individu
remain
ebv
carrier
life
develop
countri
primari
ebv
infect
asymptomat
occur
earli
life
develop
countri
primari
infect
delay
adolesc
adult
life
manifest
infecti
mononucleosi
vitro
characterist
ebv
abil
immortalis
lymphocyt
applic
normal
cervix
similar
describ
colon
cancer
develop
cervic
cancer
stage
process
predominantli
respons
infect
hpv
infect
transient
revers
hpv
effect
cervic
epithelium
possibl
hpv
infect
persist
lead
precancer
lesion
progress
cervic
cancer
factor
associ
develop
cervic
cancer
includ
earli
sexual
activ
year
age
sexual
partner
histori
genit
wart
independ
risk
factor
might
interact
hpv
includ
hiv
infect
immunosuppress
cigarett
smoke
use
research
laboratori
provid
perman
suppli
particular
cell
line
unlimit
sourc
dna
immortalis
lymphocyt
ebv
replic
remain
multipl
extrachromosom
copi
circular
viral
dna
genom
cell
latent
infect
ebv
accompani
express
set
viral
latent
gene
gene
respect
protein
well
characteris
includ
six
nuclear
antigen
ebna
lp
three
latent
membran
protein
lmp
eber
nonpolyadenyl
noncod
rna
inappropri
express
ebv
latent
gene
lead
tumour
develop
tumour
ebv
found
includ
burkitt
lymphoma
posttranspl
b
cell
lymphoma
hodgkin
diseas
nasopharyng
carcinoma
variou
latent
gene
protein
detect
two
import
one
alway
present
laboratorytransform
lymphoblastoid
cell
line
former
transcript
regul
henc
inappropri
express
gene
farreach
effect
cell
prolifer
experiment
studi
behav
oncogen
nasopharyng
carcinoma
tumour
predominantli
found
china
south
east
asia
latenc
gene
eber
frequent
found
tumour
recent
studi
use
qpcr
quantit
ebvspecif
dna
form
plasma
tumour
nearli
patient
nasopharyng
carcinoma
studi
show
amount
ebv
dna
plasma
correl
close
stage
cancer
dna
found
tumour
metastasis
author
lin
et
al
suggest
monitor
ebv
dna
plasma
effect
way
predict
outcom
treatment
convent
type
pathogen
base
phenotyp
phage
suscept
biochemistri
antigen
profil
antibiot
resist
immun
respons
fimbriat
etc
alway
success
epidemiolog
studi
chang
spectrum
infecti
agent
particularli
immunocompromis
host
hospit
outbreak
meant
newer
epidemiolog
approach
requir
complement
replac
tradit
method
five
strategi
base
characteris
pathogenderiv
dna
rna
use
circumst
nucleic
acid
hybridis
plasmid
identif
chromosom
dna
band
pattern
pcr
sequenc
three
rna
influenza
virus
b
c
distinguish
intern
groupspecif
ribonucleoprotein
influenza
b
medic
signific
sinc
epidem
pandem
occur
influenza
c
influenza
potenti
produc
pandem
infect
speci
apart
human
exampl
bird
pig
hors
contrast
influenza
b
infect
human
antigen
structur
becom
suffici
differ
caus
pandem
influenza
viral
envelop
two
import
antigen
glycoproteinshaemagglutinin
hacompos
differ
type
neuraminidas
differ
type
figur
although
envelop
antigen
capabl
produc
mani
differ
combin
seen
water
bird
smaller
number
found
human
tabl
date
limit
number
implic
humantohuman
spread
influenza
viru
pass
host
import
term
global
spread
water
bird
undergo
genet
chang
two
type
genet
antigen
driftnew
viral
strain
frequent
result
accumul
point
mutat
surfac
glycoprotein
ha
na
mutat
occur
continu
period
time
new
strain
produc
antigen
variant
nevertheless
remain
relat
virus
preced
epidem
thu
avoid
immun
surveil
develop
immun
outbreak
occur
immun
still
present
epidem
result
genet
antigen
shiftthi
result
abrupt
major
chang
antigen
ha
protein
ha
na
protein
combin
either
result
novel
ha
alon
combin
novel
na
viru
antigen
distinct
previou
one
arisen
mutat
like
sourc
new
viral
gene
water
bird
larg
reservoir
differ
ha
na
gene
get
human
via
anim
pig
directli
chicken
occur
viru
discuss
new
viral
subtyp
precursor
pandem
popul
never
expos
figur
contemporari
worldwid
threat
health
larg
avian
flu
epidem
influenza
present
infect
chicken
across
mani
south
east
asian
countri
mainland
china
first
case
human
infect
exposur
sick
bird
drop
report
hong
kong
eighteen
patient
admit
hospit
six
die
fortun
cull
million
chicken
control
particular
outbreak
sinc
human
case
recent
report
vietnam
thailand
rna
viru
two
key
surfac
glycoprotein
haemagglutinin
ha
facilit
entri
viru
host
cell
attach
sialic
acid
receptor
neuraminidas
na
involv
releas
progeni
virion
infect
cell
ha
major
determin
direct
neutralis
antibodi
also
target
influenza
vaccin
contrast
na
import
target
antivir
agent
sinc
pandem
number
import
outbreak
record
subtyp
date
given
well
host
involv
host
includ
water
bird
chicken
pig
human
worri
trend
increas
number
new
subtyp
human
well
expand
anim
involv
sinc
late
human
contract
avian
flu
die
mortal
infect
person
ill
enough
admit
spanish
flu
epidem
kill
million
peopl
howev
mortal
associ
infect
estim
consider
less
seen
avian
flu
possibl
milder
case
flu
gone
unrecognis
worri
comparison
well
broaden
host
rang
viru
particularli
involv
pig
remain
import
global
concern
contrast
common
human
influenza
viru
highli
contagi
rare
lethal
avian
flu
chicken
particularli
virul
type
kill
rapidli
caus
widespread
organ
damag
hand
easili
transmit
bird
human
human
human
far
two
probabl
case
human
human
transmiss
occur
howev
swap
genet
materi
individu
coinfect
might
produc
hybrid
avian
flu
human
flu
viru
devast
effect
anoth
way
mix
occur
call
reassort
would
involv
anim
pig
simultan
infect
human
influenza
viru
bird
flu
viru
mix
might
produc
new
virul
viru
human
gene
allow
humantohuman
spread
lethal
gene
bird
viru
dna
sequenc
viral
genom
variou
outbreak
shown
virus
hong
kong
infect
mutat
ie
dna
sequenc
differ
virus
recent
vietnam
thailand
outbreak
show
viru
resist
two
four
antivir
agent
avail
fortun
gene
remain
bird
origin
ie
viru
acquir
gene
human
influenza
viru
precursor
pandem
outbreak
bird
flu
recent
report
show
subtyp
outbreak
involv
poultri
variou
part
canada
usa
infect
result
two
human
get
mild
flulik
ill
follow
exposur
sick
poultri
one
person
die
new
york
late
influenza
infect
although
detail
occur
known
cull
mani
bird
control
risk
avian
flu
human
viru
continu
reemerg
poultri
sever
asian
countri
suggest
might
increas
pathogen
becom
widespread
close
surveil
cdc
bodi
continu
anoth
concern
clinic
featur
travel
histori
individu
might
sar
discuss
flu
viru
similar
henc
vigil
health
profession
airport
monitor
continu
particularli
travel
histori
respiratori
symptom
suggest
infect
unpredict
environ
valu
rapid
dnabas
diagnost
obviou
characteris
differ
viral
type
mode
develop
depend
analysi
ha
na
amino
acid
recent
sequenc
singlestrand
rna
genom
viru
purpos
number
collabor
centr
sequenc
rtpcr
variou
viral
strain
particularli
ha
na
gene
monitor
chang
occur
abil
identifi
function
compon
viral
ribonucleoprotein
complex
produc
rdna
mean
provid
potenti
sourc
antigen
immunis
program
anoth
contribut
molecular
medicin
come
develop
vaccin
potenti
seriou
avian
flu
viru
normal
influenza
vaccin
prepar
chicken
embryo
sinc
lethal
chicken
grown
way
addit
step
necessari
use
recombin
dna
mean
take
gene
requir
vaccin
place
less
toxic
laboratori
viru
grow
chicken
embryo
worldwid
tapeworm
echinococcu
granulosu
import
public
health
problem
lead
develop
cyst
mani
bodi
organ
hydatid
cyst
diseas
interest
featur
parasit
phenotyp
heterogen
observ
variou
isol
includ
obtain
differ
intermedi
host
sheep
cattl
goat
camel
parasit
variabl
made
difficult
understand
life
cycl
distinguish
pathogen
nonpathogen
type
determin
best
approach
treat
anim
carrier
howev
issu
less
problemat
dna
studi
provid
object
way
distinguish
differ
type
includ
potenti
distinguish
parasit
intermedi
host
make
possibl
determin
parasit
strain
like
infect
human
dnabas
taxonom
classif
echinococcu
identifi
nine
differ
genotyp
genotyp
found
particular
anim
intermedi
host
exampl
sheep
form
tasmanian
sheep
camel
cattl
hors
strain
infect
human
anoth
strain
associ
e
granulosu
infect
alaska
consid
highli
pathogen
dna
analysi
sever
affect
individu
show
case
box
anophel
insect
medic
import
associ
malaria
filariasi
arboviru
infect
nearli
recognis
speci
anophel
mosquito
howev
small
number
vector
human
diseas
import
abl
identifi
illustr
mosquito
erad
program
vietnam
fail
wrong
mosquito
target
error
discov
dna
type
occur
femal
form
differ
strain
particular
geograph
region
difficult
distinguish
nonvector
form
mosquito
mistaken
one
involv
spread
malaria
taxonom
classif
mosquito
reli
tradit
morpholog
ad
chromosom
analysi
dna
marker
recent
public
complet
genom
sequenc
anophel
gambia
open
new
sourc
inform
allow
even
better
characteris
anophel
mosquito
also
potenti
microarray
studi
gene
express
understand
better
mosquito
metabol
pathway
expand
option
therapeut
target
fungi
eukaryot
belong
separ
kingdom
plant
anim
ubiquit
environ
addit
mani
commerci
applic
human
infect
caus
fungi
mycos
superfici
eg
skin
hair
nail
deep
eg
pneumonia
system
infect
septicaemia
particular
risk
immunocompromis
mycos
lifethreaten
treatment
option
fungal
diseas
limit
recent
medic
import
fungi
today
mani
new
infecti
opportunist
fungi
emerg
larg
divers
fungal
morpholog
ecolog
habitat
wide
spectrum
clinic
consequ
complic
diagnost
approach
understand
infect
caus
organ
import
object
studi
fungi
deduc
evolutionari
comparison
determin
related
fungal
phylogenet
reli
paramet
describ
earlier
morpholog
biochemistri
stain
characterist
addit
life
cycl
eg
morpholog
appear
particularli
sexual
reproduct
structur
provid
addit
sourc
inform
comparison
howev
tradit
type
method
alway
help
sensit
enough
even
life
cycl
uninform
eg
presenc
asexu
form
coccidioid
immiti
made
classif
particularli
difficult
earli
breakthrough
fungal
taxonomi
base
dna
type
find
pneumocysti
carinii
common
seriou
infect
aid
well
immunocompromis
patient
fungu
protozoan
consid
initi
cultur
humanderiv
p
carinii
alway
difficult
life
cycl
metabol
process
poorli
understood
howev
base
rrna
dna
sequenc
comparison
organ
consid
fungu
today
new
opportun
fungal
research
result
number
organ
genom
sequenc
start
cerevisia
yeast
genom
project
complet
mani
other
progress
genom
approach
much
part
basic
research
fungi
microarray
genom
protein
appli
studi
import
pathogen
catalogu
gene
profil
organ
expect
virul
pathway
identifi
target
specif
therapi
hydatid
diseas
caus
echinococcu
granulosu
two
differ
form
north
america
domest
pastor
dog
definit
host
typic
intermedi
host
sheep
human
get
infect
exposur
e
granulosu
egg
shed
dog
sylvaticthi
found
higher
latitud
correspond
host
wolv
sled
dog
moos
reindeer
base
experi
hydatid
diseas
alaska
treatment
sylvat
form
usual
conserv
rather
surgeri
sinc
natur
histori
hydatid
diseas
higher
latitud
fairli
benign
therefor
surpris
two
patient
develop
sever
form
hydatid
diseas
alaska
one
explan
differ
clinic
profil
infect
geograph
region
visit
lower
unit
state
howev
one
patient
dna
analysi
e
granulosu
show
genotyp
ie
would
normal
found
alaska
confirm
show
number
infect
moos
carri
ident
strain
case
provid
understand
variant
e
granulosu
normal
follow
rel
benign
natur
histori
unusu
case
reason
yet
unknown
produc
sever
diseas
dna
analysi
becam
avail
level
understand
hydatid
diseas
would
possibl
epidemiolog
sens
understand
virul
pathway
facilit
investig
diseas
outbreak
particularli
nosocomi
one
sinc
allow
mix
organ
like
present
accur
type
determin
strain
subtyp
respons
infect
nosocomi
hospit
acquir
infect
includ
bloodstream
infect
pneumonia
ventilatorassoci
pneumonia
intraabdomin
sepsi
wound
infect
infect
immunocompromis
patient
pathogen
caus
infect
often
resist
mani
antimicrobi
agent
suboptim
treatment
within
hospit
environ
exacerb
problem
drug
resist
one
studi
intens
care
patient
effect
bloodstream
bacteraemia
septicaemia
nosocomi
infect
increas
stay
intens
care
unit
well
associ
financi
cost
import
nosocomi
infect
method
type
pathogen
enabl
sourc
mode
spread
identifi
composit
dna
polymorph
provid
uniqu
dna
pattern
individu
person
dna
fingerprint
popularli
known
well
establish
forens
practic
see
chapter
dnarna
profil
infecti
agent
similarli
exploit
diagnost
epidemiolog
purpos
dna
marker
select
conserv
region
microbi
genom
less
discrimin
requir
hand
choos
dna
probe
highli
variabl
ie
polymorph
region
genom
allow
discrimin
close
relat
organ
ultim
dna
fingerprint
avail
infecti
diseas
use
dna
sequenc
includ
option
sequenc
pathogen
entir
genom
legionella
spp
ubiquit
bacteria
present
domest
industri
water
system
tank
sourc
pool
collect
water
differ
speci
genu
legionella
describ
consid
rel
common
pathogen
involv
commun
acquir
well
nosocomi
legionellosi
infect
organ
easili
overlook
tradit
diagnost
test
sensit
enough
particularli
speci
common
l
pneumophila
although
air
condition
cool
tower
recognis
sourc
organ
recent
find
legionella
spp
drink
water
provid
anoth
explan
sporad
larger
outbreak
legionella
spp
found
water
suppli
mani
hospit
one
studi
hospit
test
posit
genotyp
show
hospit
differ
legionella
spp
consid
waterborn
legionella
caus
infect
contamin
aerosol
inhal
aspir
contamin
water
link
hospit
water
suppli
variou
type
nosocomi
infect
slowli
grow
dna
type
provid
evid
similar
infect
organ
found
water
suppli
tabl
proport
case
legionnair
diseas
consid
nosocomi
origin
sporad
case
outbreak
respiratori
disord
report
organ
eg
l
pneumophila
difficult
grow
frequent
necessari
obtain
bronchial
aspir
lung
biopsi
direct
detect
serolog
test
mainstay
diagnosi
although
number
dnaderiv
test
develop
test
utilis
dna
hybridis
probe
often
rrnaspecif
anoth
use
rdna
approach
fingerprint
bacteri
genom
legionella
spp
puls
field
gel
electrophoresi
pfge
intens
care
unit
p
aeruginosa
infect
genotyp
organ
show
studi
aeruginosa
origin
endogen
gut
flora
tap
patient
room
sourc
infect
patient
third
case
mycobacteria
spp
nontb
form
mycobacteria
caus
nonsteril
ice
inappropri
use
tap
water
wide
rang
infect
includ
abscess
rins
instrument
shown
dna
type
use
cathet
endoscop
anoth
sourc
infect
surgic
site
site
relat
dialysi
aspergillu
lifethreaten
infect
threeyear
prospect
studi
aspergillu
detect
immunosuppress
patient
thought
hospit
water
system
higher
titr
found
caus
fungal
particl
air
bathroom
genotyp
one
isol
aspergillu
fumigatu
infect
patient
show
fungu
isol
recov
shower
wall
patient
room
techniqu
allow
larg
segment
dna
separ
use
restrict
enzym
noti
sfii
digest
dna
infrequ
upper
limit
resolut
convent
dna
gel
electrophoresi
approxim
kb
wherea
puls
field
gel
electrophoresi
approach
mb
kb
puls
field
gel
electrophoresi
particularli
attract
microbiolog
work
genom
infecti
agent
rel
small
exampl
total
dna
legionella
spp
cleav
limit
number
fragment
noti
depend
strain
fragment
fingerprint
directli
visualis
ethidium
bromid
stain
gel
therebi
avoid
requir
dna
probe
hybridis
step
howev
techniqu
demand
surprisingli
pcrbase
approach
increasingli
becom
prefer
method
dna
fingerprint
type
legionella
spp
epidemiolog
purpos
follow
similar
strategi
first
isol
methicillin
resist
aureu
report
one
year
methicillin
becam
avail
follow
emerg
vancomycinresist
mrsa
mrsa
develop
aureu
acquir
larg
segment
dna
call
sccmec
integr
aureu
chromosom
segment
dna
look
like
antibiot
resist
cassett
contain
gene
b
lactam
resist
gene
resist
nonblactam
antibiot
vancomycin
resist
thought
occur
emerg
strain
aureu
thicken
cell
wall
therebi
prevent
vancomycin
get
pathogen
antibioticresist
aureu
import
frequent
caus
nosocomi
infect
hospit
occur
infect
control
protocol
need
identifi
sourc
methicillinresist
aureu
determin
whether
breakdown
infect
control
practic
effect
prevent
measur
implement
futur
occur
differ
bacteri
subtyp
need
distinguish
phage
type
tradit
tool
epidemiolog
studi
involv
aureu
howev
method
poor
reproduc
abl
type
isol
impract
laboratori
sinc
requir
larg
number
phage
stock
maintain
phage
type
replac
dnabas
test
like
exampl
legionella
mrsa
type
involv
wide
rang
techniqu
pfge
pcr
although
techniqu
often
discriminatori
tradit
approach
need
standardis
allow
better
interlaboratori
comparison
made
emerg
infect
describ
infect
newli
identifi
whose
incid
human
significantli
increas
past
year
mani
factor
contribut
emerg
infect
includ
chang
human
behaviour
globalis
ie
increas
travel
tourism
technolog
advanc
econom
develop
chang
environ
laps
public
health
measur
includ
result
poverti
war
emerg
infect
repres
novel
pathogen
result
chang
epidemiolog
virul
pathogen
secondari
microbi
adapt
import
sourc
emerg
infect
anim
past
emerg
infecti
agent
reflect
chang
pattern
human
movement
disrupt
tradit
geograph
boundari
exampl
yellow
fever
thought
emerg
new
world
result
african
slave
trade
brought
mosquito
aed
aegypti
ship
water
contain
recent
aed
albopictu
potenti
vector
dengu
viru
becom
establish
usa
follow
convey
south
east
asia
old
car
tyre
threat
dengu
north
american
contin
becom
real
emerg
virus
zoonot
ie
acquir
anim
reservoir
infect
thu
complet
new
strain
less
like
appear
viru
follow
chang
anim
reservoir
particularli
relev
modern
world
consequ
easi
migrat
deforest
agricultur
practic
dam
build
urbanis
make
continu
major
impact
ecolog
anim
time
human
increasingli
popul
rural
area
pursu
outdoor
recreat
activ
also
grow
trend
keep
exot
anim
household
pet
chang
global
climat
may
also
contribut
directli
effect
veget
insect
rodent
popul
tabl
list
number
zoonos
becom
establish
new
infecti
diseas
emerg
problem
futur
newli
acquir
west
wherea
other
remain
endem
specif
countri
mani
case
molecular
medicin
offer
littl
current
manag
includ
diagnosi
although
much
knowledg
infect
come
analysi
organ
dna
rna
howev
potenti
spread
diseas
high
intern
travel
mass
disloc
larg
popul
follow
civil
unrest
also
increas
awar
number
pathogen
could
use
bioterror
zoonos
associ
viral
haemorrhag
clinic
pictur
confus
clinic
infect
includ
malaria
leptospirosi
neisseria
meningitidi
potenti
fatal
condit
rapid
screen
test
essenti
term
bioterror
differenti
diagnosi
haemorrhag
fever
pcr
nat
base
assay
present
option
potenti
allow
rapid
sensit
diagnost
test
develop
sar
sever
acut
respiratori
syndrom
attract
lot
public
provok
fear
describ
first
pandem
twentyfirst
centuri
sinc
involv
patient
caus
death
countri
five
contin
peiri
et
al
econom
impact
infect
hong
kong
estim
nearli
us
billion
sar
also
repres
contemporari
paradigm
illustr
valu
molecularbas
dna
approach
deal
seriou
emerg
infect
journal
scienc
acknowledg
impress
work
undertaken
control
sar
cite
outstand
achiev
year
sar
pandem
prevent
see
tabl
chronolog
event
sar
stori
given
tabl
tradit
approach
viral
cultur
electron
microscopi
serolog
play
key
role
characteris
sar
viru
shown
coronaviru
cov
nevertheless
molecular
approach
enabl
follow
key
inform
obtain
short
time
frame
molecular
type
viru
outbreak
taiwan
confirm
viru
ident
dna
sequenc
viru
isol
hong
kong
outbreak
ie
humantohuman
spread
occur
individu
hong
kong
similar
comparison
possibl
link
variou
outbreak
molecular
epidemiolog
rapid
whole
genom
sequenc
viral
rna
provid
firm
base
develop
pcrbase
diagnost
assay
critic
requir
acut
infect
sarscov
search
anim
reservoir
rtpcrbase
techniqu
use
enabl
sarscov
detect
well
identifi
genet
differ
human
anim
viru
futur
understand
viru
evolv
strain
pathogen
mode
spread
popul
could
address
dna
approach
us
nation
institut
allergi
infecti
diseas
releas
genom
chip
contain
full
base
pair
sar
viral
genom
sar
outbreak
end
quickli
start
occasion
case
report
earli
none
report
end
april
year
howev
remain
mani
unansw
question
includ
inconsist
humantohuman
transmiss
document
case
one
infect
passeng
transmit
number
other
particular
flight
anoth
flight
transmiss
occur
despit
number
passeng
ill
viru
inconsist
explain
propos
immunosuppress
concern
hold
back
need
xenotransplant
xenotranspl
infect
superspread
anoth
intrigu
observ
sar
rel
larg
number
health
worker
infect
ie
sar
transmiss
seem
like
within
hospit
set
although
number
emerg
virus
describ
recent
sarscov
particularli
worri
one
shown
humantohuman
transmiss
although
fortun
seem
rel
ineffici
futur
key
issu
earli
prompt
recognit
new
case
enabl
tradit
public
health
measur
reason
effect
contain
occas
although
season
chang
may
also
contribut
implement
even
faster
also
flag
import
laboratori
contain
deal
viru
becam
issu
two
nine
person
infect
china
work
refer
laboratori
conduct
research
sarscov
similar
scenario
report
earlier
singapor
latter
case
clearli
document
dna
sequenc
viru
due
contamin
laboratori
cultur
scientist
work
three
day
show
sign
infect
issu
still
outstand
sarscov
viru
normal
spread
communic
respiratori
infect
tradit
infect
other
droplet
spread
contact
contamin
surfac
preliminari
data
report
sarscov
involv
airborn
transmiss
proven
interest
public
health
challeng
requir
better
understand
mode
transmiss
includ
relationship
modern
hous
travel
work
environ
detect
viral
particl
involv
airborn
spread
easi
pcr
becom
indispens
tool
public
health
profession
anthrax
bioterror
case
usa
world
place
alert
new
form
modern
terror
launch
chapter
refer
made
us
govern
move
develop
microbi
forens
way
deal
bioterror
biocrim
involv
use
human
anim
pathogen
dna
technolog
particularli
valuabl
asset
microbi
forens
allow
rapid
identif
variou
pathogen
part
detect
work
find
sourc
infect
discuss
chapter
fortuit
compon
human
genom
project
sequenc
genom
number
pathogen
inform
need
combat
bioterror
biolog
warfar
bioterror
possibl
mani
way
includ
contamin
food
water
suppli
via
infect
anim
includ
insect
seriou
form
would
involv
use
aerosol
contain
pathogen
risk
infect
larg
number
peopl
length
incub
period
also
consider
sinc
would
degre
influenc
number
infect
contain
treatment
initi
biosensor
develop
assist
earli
detect
infect
dnabas
chip
technolog
tri
way
microb
detect
directli
dna
sequenc
ensur
rapid
detect
type
pathogen
two
pathogen
particular
relev
bioterror
anthrax
smallpox
dnabas
genotyp
alreadi
proven
valu
case
us
anthrax
case
box
promis
report
suggest
pathogen
anthrax
could
detect
within
hour
realtim
pcr
smallpox
anoth
seriou
infect
sinc
routin
vaccin
stop
usa
earli
leav
mani
unvaccin
vulner
target
countri
asia
case
fatal
rate
around
observ
epidem
known
treatment
smallpox
part
biolog
warfar
program
former
soviet
union
produc
smallpox
anthrax
pathogen
remain
concern
could
fall
hand
potenti
terrorist
bse
mad
cow
diseas
caus
prion
ie
abnorm
form
protein
prp
spread
one
organ
anoth
interfer
shape
normal
protein
gene
produc
prp
protein
call
prnp
two
form
prp
c
normal
protein
c
cellular
prp
sc
abnorm
protein
sc
scrapi
uk
bse
result
feed
contamin
food
cattl
similar
diseas
found
sheep
goat
call
scrapi
human
diseas
call
cjd
creutzfeldtjakob
diseas
number
form
cjd
sporad
type
rare
occur
elderli
inherit
form
also
rare
shown
mutat
prnp
gene
iatrogen
cjd
occur
contamin
instrument
human
product
prion
tradit
pathogen
sterilis
method
effect
variant
cjd
vcjd
result
direct
animaltohuman
spread
contamin
beef
product
vcjd
transmit
blood
long
incub
period
possibl
perhap
year
exclud
disturb
experiment
data
suggest
possibl
anthrax
caus
b
anthraci
gram
posit
sporeform
organ
usual
acquir
human
exposur
infect
anim
product
contamin
dust
major
form
anthrax
cutan
case
mortal
pulmonari
mortal
treat
symptom
develop
octob
novemb
follow
septemb
world
trade
centr
disast
cutan
inhal
case
anthrax
occur
florida
new
york
citi
new
jersey
washington
dc
connecticut
exampl
bioterror
sinc
bacteria
came
one
sourc
base
dna
type
show
ident
genotyp
like
rout
infect
intent
contamin
mail
apart
two
case
other
mail
govern
worker
employe
news
media
outlet
two
except
woman
new
york
citi
woman
connecticut
die
develop
inhal
anthrax
possibl
detect
like
sourc
infect
case
connecticut
victim
postal
process
distribut
centr
pdc
letterrel
case
identifi
find
contamin
bacteria
howev
victim
sampl
home
person
item
test
posit
b
anthraci
known
receiv
mail
includ
junk
bulk
mail
one
pdc
also
subsequ
shown
local
pdc
southern
connecticut
heavili
contamin
sort
machin
assum
b
anthraci
ident
involv
outbreak
infect
letter
directli
contamin
pdc
implic
earlier
infect
secondarili
contamin
southern
connecticut
pdc
past
centuri
steadi
declin
infecti
diseas
affluent
countri
diseas
becom
rel
minor
problem
compar
increas
role
play
chronic
neoplast
diseas
situat
start
chang
onset
aid
relat
infect
tuberculosi
emerg
infect
appear
import
concern
futur
hepat
c
viru
exampl
pathogen
start
impact
health
wellb
mani
commun
although
emot
forc
hiv
import
modern
scourg
need
spread
control
effect
infect
need
access
antivir
agent
box
key
control
spread
modern
pathogen
effect
vaccin
develop
basi
organ
genom
sequenc
call
revers
vaccinolog
illustr
group
b
meningococcu
vaccin
could
develop
tradit
mean
howev
soon
genom
sequenc
possibl
identifi
mani
potenti
vaccin
candid
test
clinic
trial
genom
era
open
new
opportun
control
infecti
diseas
sar
exampl
also
illustr
valu
genom
public
health
medicin
particular
rapid
sequenc
genom
appear
coronaviruslik
pathogen
enabl
definit
diagnosi
made
potenti
vaccin
target
identifi
alreadi
anim
phase
test
develop
technolog
address
mani
potenti
problem
relat
dna
test
microbiolog
challeng
futur
better
understand
find
dna
rna
sequenc
mean
term
infect
pathogenesi
tradit
approach
mani
year
experi
help
interpret
result
posit
cultur
experi
avail
dna
test
necessari
hard
work
determin
signific
variou
dna
test
exampl
would
persist
mycobacteri
growth
cultur
despit
treatment
would
suggest
complianc
issu
develop
drug
resist
find
persist
posit
dna
test
circumst
would
difficult
interpret
valid
posit
dna
test
result
necessari
wide
rang
infect
exampl
find
cmv
dna
pcr
patient
serum
could
mean
activ
diseas
latent
infect
issu
resolv
import
integr
molecular
diagnost
routin
microbiolog
laboratori
practic
doubt
potenti
genom
allow
novel
way
detect
infect
pathogen
one
earli
model
describ
involv
use
microarray
detect
gene
profil
patient
rather
attempt
detect
pathogenspecif
nucleic
acid
use
approach
claim
peripher
blood
mononuclear
cell
expos
tuberculosi
protozoan
leishmania
donovani
worm
brugia
malay
demonstr
discret
express
profil
particular
infecti
agent
thirteen
year
term
nona
nonb
hepat
first
use
hcv
viru
found
mileston
molecular
virolog
came
hcv
clone
year
visualis
cultur
even
characteris
base
amino
acid
sequenc
genom
organis
hcv
class
separ
genu
viral
famili
flavivirida
hcv
rna
viru
six
genotyp
main
sourc
infect
today
intraven
drug
use
transfusionrel
hcv
rare
seen
effect
screen
method
place
unlik
hbv
mothertoinf
sexual
transmiss
rare
nearli
million
peopl
worldwid
infect
hcv
common
reason
liver
transplant
usa
unlik
hbv
infrequ
lead
chronic
hepat
infect
hcv
develop
complic
like
hbv
hepat
damag
caus
hcv
thought
secondari
immun
respons
rather
direct
viral
effect
addit
age
male
sex
alcohol
consumpt
coexist
hiv
infect
low
count
metabol
disord
diabet
predispos
develop
liver
cirrhosi
subsequ
hepatocellular
cancer
like
hiv
excel
serolog
dnabas
assay
avail
accur
diagnosi
quantit
rna
assay
genotyp
enabl
predict
made
individu
respond
antivir
therapi
treatment
use
interferon
alpha
ribavirin
effect
particularli
hcv
genotyp
respons
rate
compar
four
genotyp
howev
inadequ
detect
money
pay
drug
consider
concern
seen
present
tip
iceberg
sinc
viru
long
incub
period
mani
carrier
remain
asymptomat
complic
develop
